Colorescience, Inc. CEO and leadership

Mary Fisher brings more than 25 years of experience in the pharmaceutical and biotechnology industries. Ms. Fisher currently serves as Chief Executive Officer and Director at Colorescience, a former division of SkinMedica, Inc., where she served as Chief Executive Officer from 2008 until 2012, when she led the successful sale of the company to Allergan, Inc. for $375 million. Prior to joining SkinMedica, Ms. Fisher was the Chief Operating Officer of Acorda Therapeutics, a biotechnology company focused on developing products for the treatment of central nervous system disorders. There, she helped execute the company’s restructuring, initial public offering and a $50 million acquisition that transitioned Acorda from a developmental platform to a commercial stage operation. Ms. Fisher has served as a Pharmaceutical Consultant for companies such as Acorda Therapeutics and Roche Diagnostics and specialized in commercialization strategy, resource and outsource planning, pricing strategy and tactics, distribution planning, managed care contracting and forecasting. Previously, she held the role of Vice President, Strategic Healthcare and Commercial Operations at Cephalon, Inc., and Manager, Communications at Immunex. She currently serves as a Board Member of Zeltiq, a Board Member of OvaScience, as well as the Neuroscience Nursing Foundation and is a Member of the Women’s Dermatological Society and the Dermatology Foundation Leader’s Society.

Steve Loomis joined Colorescience in May 2013 as Chief Financial Officer after three years at SkinMedica, where he served as as Senior Vice President of Finance, Chief Financial Officer and Corporate Secretary. From 1996 to February 2010, Mr. Loomis served as Vice President of Finance, Chief Financial Officer and Corporate Secretary for CardioDynamics International Corporation, a publicly traded international medical device company, and in 2008, he was appointed to the additional role of Vice President of Operations. From 1993 until 1996, he served as Director of Financial Reporting at Kinko's Inc. a worldwide business service provider. From 1988 to 1993, Mr. Loomis was Chief Financial Officer for Terminal Data Corporation, a publicly traded international high technology manufacturing company. He earned his Bachelor's degree in business administration from California State University at Northridge. Mr. Loomis is a certified public accountant and has served on the board of several for-profit and not-for-profit organizations. Mr. Loomis was awarded San Diego Business Journal's 2011 CFO of the Year.

Experienced Chief Business Officer and Board Member with a demonstrated history of working in the life sciences, consumer products, cosmetics and nutritional supplement industries. Skilled in Commercial Leadership, Business Planning, Marketing, E-commerce, Corporate Development, Regulatory Compliance and Portfolio Management. Strong business development professional graduated from University of Pennsylvania - The Wharton School.

Mary Fisher brings more than 25 years of experience in the pharmaceutical and biotechnology industries. Ms. Fisher currently serves as Chief Executive Officer and Director at Colorescience, a former division of SkinMedica, Inc., where she served as Chief Executive Officer from 2008 until 2012, when she led the successful sale of the company to Allergan, Inc. for $375 million. Prior to joining SkinMedica, Ms. Fisher was the Chief Operating Officer of Acorda Therapeutics, a biotechnology company focused on developing products for the treatment of central nervous system disorders. There, she helped execute the company’s restructuring, initial public offering and a $50 million acquisition that transitioned Acorda from a developmental platform to a commercial stage operation. Ms. Fisher has served as a Pharmaceutical Consultant for companies such as Acorda Therapeutics and Roche Diagnostics and specialized in commercialization strategy, resource and outsource planning, pricing strategy and tactics, distribution planning, managed care contracting and forecasting. Previously, she held the role of Vice President, Strategic Healthcare and Commercial Operations at Cephalon, Inc., and Manager, Communications at Immunex. She currently serves as a Board Member of Zeltiq, a Board Member of OvaScience, as well as the Neuroscience Nursing Foundation and is a Member of the Women’s Dermatological Society and the Dermatology Foundation Leader’s Society.